معرفی
Huy ONG is an Associate Professor and Emeritus Professor at the Faculty of Pharmacy, Université de Montréal. His research focuses on therapeutic target discovery, cardiovascular and metabolic pharmacology, endocrinology, and inflammation, with notable contributions to understanding CD36 receptor modulation in diseases like age-related macular degeneration and atherosclerosis. He has supervised over 30 graduate students, including PhD and Master's candidates, and leads collaborative projects on drug development for ophthalmic and cardiovascular conditions.
Key affiliations include the GRUM (Drug Research Group) and RQRV (Quebec Network on Aging). His work has been supported by grants from the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation, and Quebec's Ministry of Economy and Innovation. Notable projects include developing azapeptide ligands for treating macular degeneration and ischemic heart disease, alongside colleagues Sylvain Chemtob and William Lubell.
Research highlights include groundbreaking studies on CD36's role in immunometabolism and anti-inflammatory therapies. His interdisciplinary approach bridges pharmacy, chemistry, and medicine, with potential clinical applications in near future. Over 40 years of academic service at Université de Montréal reflect his dedication to advancing pharmaceutical science.
